Compare Innodata Inc (INOD) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innodata Inc vs Summit Therapeutics Inc — how do they compare? Innodata Inc trades at $63.94 (market cap $2.03B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Summit Therapeutics Inc is far larger — about 5.2× Innodata Inc's market cap, and Innodata Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| INOD | SMMT | |
|---|---|---|
Market Cap | $2.03B | $10.48B |
Sector | Technology | Health |
52-Week High | $121.50 | $29.32 |
52-Week Low | $34.45 | $13.05 |
Enterprise Value | $1.91B | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
